-
1دورية أكاديمية
المؤلفون: Oran, Betül, Ahn, Kwang Woo, Fretham, Caitrin, Beitinjaneh, Amer, Bashey, Asad, Pawarode, Attaphol, Wirk, Baldeep, Scott, Bart L, Savani, Bipin N, Bredeson, Christopher, Weisdorf, Daniel, Marks, David I, Rizzieri, David, Copelan, Edward, Hildebrandt, Gerhard C, Hale, Gregory A, Murthy, Hemant S, Lazarus, Hillard M, Cerny, Jan, Liesveld, Jane L, Yared, Jean A, Yves-Cahn, Jean, Szer, Jeffrey, Verdonck, Leo F, Aljurf, Mahmoud, van der Poel, Marjolein, Litzow, Mark, Kalaycio, Matt, Grunwald, Michael R, Diaz, Miguel Angel, Sabloff, Mitchell, Kharfan-Dabaja, Mohamed A, Majhail, Navneet S, Farhadfar, Nosha, Reshef, Ran, Olsson, Richard F, Gale, Robert Peter, Nakamura, Ryotaro, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Farhan, Shatha, Ganguly, Siddhartha, Nathan, Sunita, Nishihori, Taiga, Jain, Tania, Agrawal, Vaibhav, Bacher, Ulrike, Popat, Uday, Saber, Wael
المساهمون: Medicine
المصدر: Transplantation and cellular therapy ; 27 ; 11 ; 921.e1 ; 921.e10 ; United States
مصطلحات موضوعية: MDS, Melphalan, Relapse, Survival, Transplantation
العلاقة: Transplantation and Cellular Therapy; https://doi.org/10.1016/j.jtct.2021.08.007Test; Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther. 2021 Nov;27(11):921.e1-921.e10. doi:10.1016/j.jtct.2021.08.007. Epub 2021 Aug 14. PMID: 34403791; PMCID: PMC9562611.; http://hdl.handle.net/20.500.14038/51890Test
الإتاحة: https://doi.org/10.1016/j.jtct.2021.08.007Test
https://doi.org/20.500.14038/51890Test
https://hdl.handle.net/20.500.14038/51890Test -
2دورية أكاديمية
المؤلفون: Oran, Betül, Ahn, Kwang Woo, Fretham, Caitrin, Beitinjaneh, Amer, Bashey, Asad, Pawarode, Attaphol, Wirk, Baldeep, Scott, Bart L., Savani, Bipin N., Bredeson, Christopher, Weisdorf, Daniel, Marks, David I., Rizzieri, David, Copelan, Edward, Hildebrandt, Gerhard C., Hale, Gregory A., Murthy, Hemant S., Lazarus, Hillard M., Cerny, Jan, Liesveld, Jane L., Yared, Jean A., Yves-Cahn, Jean, Szer, Jeffrey, Verdonck, Leo F., Aljur, Mahmoud, van der Poel, Marjolein, Litzow, Mark, Kalaycio, Matt, Grunwald, Michael R., Diaz, Miguel Angel, Sabloff, Mitchell, Kharfan-Dabaja, Mohamed A., Majhail, Navneet S., Farhadfar, Nosha, Reshef, Ran, Olsson, Richard F., Gale, Robert Peter, Nakamura, Ryotaro, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Farhan, Shatha, Ganguly, Siddhartha, Nathan, Sunita, Nishihori, Taiga, Jain, Tania, Agrawal, Vaibhav, Bacher, Ulrike, Popat, Uday, Saber, Wael
المساهمون: Medicine, School of Medicine
المصدر: PMC
مصطلحات موضوعية: MDS, Melphalan, Relapse, Survival, Transplantation
وصف الملف: application/pdf
العلاقة: Transplantation and Cellular Therapy; Oran B, Ahn KW, Fretham C, et al. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther. 2021;27(11):921.e1-921.e10. doi:10.1016/j.jtct.2021.08.007; https://hdl.handle.net/1805/35894Test
-
3
المؤلفون: Htut, Myo, D'Souza, Anita, Krishnan, Amrita, Bruno, Benedetto, Zhang, Mei-Jie, Fei, Mingwei, Diaz, Miguel Angel, Copelan, Edward, Ganguly, Siddhartha, Hamadani, Mehdi, Kharfan-Dabaja, Mohamed, Lazarus, Hillard, Lee, Cindy, Meehan, Kenneth, Nishihori, Taiga, Saad, Ayman, Seo, Sachiko, Ramanathan, Muthalagu, Usmani, Saad Z, Gasparetto, Christina, Mark, Tomer M, Nieto, Yago, Hari, Parameswaran
المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madridمصطلحات موضوعية: Adult, Male, Survival, Hematopoietic Stem Cell Transplantation, Myeloma, Middle Aged, Allografts, Disease-Free Survival, Survival Rate, Sex Factors, Recurrence, Risk Factors, Allogeneic transplantation, Humans, Female, Relapse, Autografts, Multiple Myeloma, Aged
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3a9c27411c6b0ae966f908b1ef5d8619Test
https://hdl.handle.net/20.500.12530/29949Test -
4دورية أكاديمية
المؤلفون: Dean, Robert M., Pohlman, Brad, Sweetenham, John W., Sobecks, Ronald M., Kalaycio, Matt E., Smith, Stephen D., Copelan, Edward A., Andresen, Steven, Rybicki, Lisa A., Curtis, Julie, Bolwell, Brian J.
المصدر: British Journal of Haematology; Jan2010, Vol. 148 Issue 2, p226-234, 9p, 4 Charts, 4 Graphs
مصطلحات موضوعية: AUTOTRANSPLANTATION, CELL transplantation, CYCLOPHOSPHAMIDE, ETOPOSIDE, PHARMACOKINETICS, LYMPHOMAS